Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Ethris Announces Collaboration with DIOSynVax and CEPI to Develop a Broadly Protective mRNA Vaccine Against Betacoronaviruses
Thursday, December 22, 2022Ethris GmbH a leading biotechnology company pioneering nextgeneration messenger RNA mRNA therapeutics and vaccines announced today a collaboration with UKbased DIOSynVax to jointly develop a protective mRNA vaccine candidate against a broad range of...
Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company
Thursday, December 22, 2022Berkeley Lights a life sciences tools company and IsoPlexis Nasdaq ISO a company empowering labs to leverage the cells and proteome changing the course of human health today announced a definitive agreement under which Berkeley Lights will acquire Is...
Kite to Acquire Tmunity Therapeutics to Pursue Next Generation CAR T-Cell Therapy Advancements in Cancer
Wednesday, December 21, 2022Kite a Gilead Company and Tmunity Therapeutics Tmunity today announced that the companies have signed an agreement in which Kite will acquire Tmunity a clinicalstage private biotech company focused on nextgeneration CAR Ttherapies and technologies Th...
Skye Bioscience Receives FDA Authorization of Investigational New Drug Application for SBI-100 OE
Wednesday, December 21, 2022Skye Bioscience Inc a pharmaceutical company developing a proprietary synthetic cannabinoid derivative to treat glaucoma today announced that the US Food and Drug Administration FDA has given the okay to proceed for the Investigational New Drug IND a...
Sanofi and Innate Pharma expand collaboration for natural killer cell therapeutics in oncology
Tuesday, December 20, 2022Sanofi and Innate Pharma SA announced today an expansion of their collaboration with Sanofi licensing a natural killer NK cell engager program targeting BH from Innates ANKETTM Antibodybased NK Cell Engager Therapeutics platform Sanofi will also have...
Bioasis Technologies Inc. Announces Amendments to Arrangement Agreement with Midatech Pharma plc
Tuesday, December 20, 2022Bioasis Technologies Inc a multiasset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and a differentiated proprietary xB platform for delivering therapeutics across the bloodbra...
Enhertu approved in the EU for patients with previously treated HER2-positive advanced gastric cancer
Tuesday, December 20, 2022AstraZeneca and Daiichi Sankyos Enhertu trastuzumab deruxtecan has been approved in the European Union EU as monotherapy for the treatment of adult patients with advanced HERpositive gastric or gastroesophageal junction GEJ adenocarcinoma who have re...
Psyence and Filament Health Announce Worldwide Licensing Agreement of Psilocybin Capsule for Palliative Care
Friday, December 16, 2022Filament Health Corp a clinicalstage natural psychedelic drug development company and Psyence Group Inc a life science biotechnology company pioneering the use of natural psilocybin in mental health and wellbeing today announced the conclusion of a r...
Fresenius Kabi Targets Treatment of Certain Seizures with Launch of Generic Lacosamide Injection, USP
Friday, December 16, 2022Fresenius Kabi announced today the immediate availability in the US of Lacosamide Injection USP a generic equivalent to VIMPAT Fresenius Kabi Lacosamide Injection USP is an approved treatment option for partialonset seizures in patients years of age...
Exicure, Inc. Announces Termination of AbbVie and Ipsen Collaboration Agreements
Thursday, December 15, 2022Exicure Inc an earlystage biotechnology company historically focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets today announced the termination of its collaboration agreements with AbbVie Inc AbbVie and...
